CompaniesPrecision for Medicine
Precision for Medicine logo

Precision for Medicine

active
Frederick, MD, United States
Founded 2012
Website
About

Services / Consulting

Areas of Focus

Categories

Clinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchBiostorageClinical ResearchClinical ResearchClinical ResearchServicesVirginia, DC, DE & Maryland
Team (25)
Amanda Woodrooffe
Amanda Woodrooffe
Amanda Woodrooffe, PhD
Precision for Medicine
team_member
Andrea Cotton-Berry
Andrea Cotton-Berry
Andrea Cotton-Berry
Precision for Medicine
team_member
Carolyn Harley
Carolyn Harley
Carolyn Harley
Precision for Medicine
team_member
Chad Clark
Chad Clark
Chad Clark
Precision for Medicine
team_member
Daisy DeWeese-Gatt
Daisy DeWeese-Gatt
Daisy DeWeese-Gatt, MPH
Precision for Medicine
team_member
Darren Davis
Darren Davis
Darren Davis, PhD
Precision for Medicine
team_member
View all 25 team members →
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

0

As Collaborator

6

Total Enrollment

643

By Phase

PHASE1: 2PHASE2: 3PHASE3: 1

By Status

COMPLETED: 5RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT02963493
NCT04410133
NCT06789172
Hover over trial bars to see details

Recent Trials

NCT06789172Collaborator
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
PHASE1Recruiting
166 participants
Started: Jan 23, 2025 · Completed: Sep 30, 2028
NCT05414422Collaborator
A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD
PHASE2Completed
102 participants
Started: Feb 1, 2022 · Completed: Nov 10, 2022
NCT04410133Collaborator
Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases
PHASE3Completed
151 participants
Started: Oct 26, 2020 · Completed: Jun 5, 2023
NCT04410367Collaborator
Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)
PHASE2Completed
23 participants
Started: Aug 31, 2020 · Completed: Dec 31, 2021
NCT03844191Collaborator
A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4
PHASE1Completed
44 participants
Started: Feb 18, 2019 · Completed: Dec 1, 2019
View all 6 trials →
Locations (1)
Headquarters
Frederick, MD, United States
Map

Loading map...